D-Wave Quantum: A Rebound, a Cut Target and a Korean Handshake All Await the Same November 10 Test
Published on 11/04/2026 at 05:50 | Editorial boerse-global.de
D-Wave Quantum shares rose 2.8% yesterday as quantum computing names recovered from a broad selloff in growth technology stocks, with media reports noting that the company and its peers advanced together. A separate report put the same day's gain at 3.0%. Either way, no company-specific catalyst was identified — a detail that matters more than the headline number.
That absence tells you something. A session like this speaks to returning appetite for risk across the sector, not to a fresh business breakthrough. The move isn't meaningless, but its informational value is limited. When investors pick up several quantum stocks at once, the first thing you're watching is a sector rotation. Reading it as confirmation of D-Wave's own commercial trajectory skips a step.
What the tape can't tell you
The more useful question isn't whether quantum computing is back in favor. It's what, if anything, can already be counted as concrete economic progress at D-Wave. Three items from the past week or so are worth separating out.
First, the non-binding letter of intent signed with LG CNS. The two companies aim to push quantum computing into optimization work for enterprises in South Korea and international markets, with D-Wave's annealing technology at the center of complex optimization problems. The agreement is explicitly non-binding — it describes a possible direction of travel, not a committed order. That distinction should survive even on a good day for the stock.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
Second, the research prize won by customer Shionogi, announced roughly a week ago. Shionogi took first place in the quality-of-life category at the NEDO Quantum Computing Challenge for work on applying quantum computing to drug discovery. It's a genuine application reference for the technology, but the award went to the customer. It supports the use-case story without putting a dollar figure on any D-Wave business success.
Third, and reported yesterday, B. Riley Securities analyst Craig Ellis trimmed his price target to $27 from $40 while keeping his Buy rating. That combination deserves unpacking. The retained Buy signals confidence in the road ahead; the lower target shows the valuation yardstick has been pulled in. Anyone reading only the rating is filtering out the more cautious half of the message. The cut was reported against a backdrop of weak quantum and technology names, though it doesn't pin down what drove yesterday's move — better read as a mark of tempered expectations than as an explanation for the rally.
The date that matters
D-Wave has scheduled third-quarter 2026 results for November 10, before the market opens. That is the next announced occasion to test the stock's narrative against actual numbers, and neither a friendly price reaction nor a single positive headline can pre-empt what it will show.
Here runs the line between an interesting technology story and its market valuation. Partnerships and research wins provide footholds. Their economic weight has to be judged on its own terms. A cautious read — one that keeps research, intent and commercial success in separate boxes — looks more convincing than enthusiasm over individual signals.
Ad
D-Wave Quantum Stock: New Analysis - 4 November
Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
